Closed
1.538 2.26
24h
Min
1.5
Max
1.538
Income | 57K -25M |
---|---|
Sales | -8M 4.3M |
Profit margin | -570.732 |
Employees | 181 |
EBITDA | 2.5M -23M |
Recommendations | Neutral |
---|---|
12 Months Forecast | +106.39% upside |
Next Earnings | 17 Sept 2025 |
---|
Market Cap | 117K 153M |
---|---|
Previous open | -0.72 |
Previous close | 1.538 |
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 3.096 EUR 106.39%
High 3.1 EUR
Low 3.1 EUR
Based on 1 Wall Street analysts offering 12 month price targets forInnate Pharma SA - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$